• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to letter to the editor: Use, response and outcomes of second line chemotherapy in patients with advanced biliary tract cancers.

作者信息

Mathers Brittney, Abadi Shirin, Davies Janine M, McIntyre Connor, Ho Cheryl

机构信息

Department of Pharmacy, BC Cancer, Vancouver, BC, Canada.

Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.

出版信息

J Oncol Pharm Pract. 2023 Jun;29(4):1027. doi: 10.1177/10781552231165698. Epub 2023 Mar 27.

DOI:10.1177/10781552231165698
PMID:36972505
Abstract
摘要

相似文献

1
Response to letter to the editor: Use, response and outcomes of second line chemotherapy in patients with advanced biliary tract cancers.对编辑来信的回复：晚期胆管癌患者二线化疗的使用、反应及结果
J Oncol Pharm Pract. 2023 Jun;29(4):1027. doi: 10.1177/10781552231165698. Epub 2023 Mar 27.
2
Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers.二线化疗在晚期胆道癌患者中的应用、反应和结局。
J Oncol Pharm Pract. 2023 Sep;29(6):1381-1386. doi: 10.1177/10781552221122058. Epub 2022 Nov 1.
3
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial.regorafenib 治疗局部晚期/转移性胆道肿瘤gemcitabine 和铂类化疗失败后的疗效：REACHIN，一项随机、双盲、II 期试验。
Ann Oncol. 2020 Sep;31(9):1169-1177. doi: 10.1016/j.annonc.2020.05.018. Epub 2020 May 25.
4
Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial.吉西他滨和顺铂或奥沙利铂化疗联合阿替利珠单抗加贝伐珠单抗治疗晚期胆道癌：一项单臂试验。
Future Oncol. 2023 May;19(15):1029-1035. doi: 10.2217/fon-2022-0189. Epub 2023 May 3.
5
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study).阿昔替尼单药治疗吉西他滨为基础的化疗难治性晚期胆道癌的多中心 II 期临床试验（AX-BC 研究）。
Oncologist. 2021 Feb;26(2):97-e201. doi: 10.1002/onco.13547. Epub 2020 Oct 17.
6
A retrospective study of chemotherapy with cisplatin plus gemcitabine after the failure of gemcitabine monotherapy for biliary tract cancer.吉西他滨单药治疗失败后顺铂联合吉西他滨化疗治疗胆道癌的回顾性研究。
Jpn J Clin Oncol. 2013 Jun;43(6):636-40. doi: 10.1093/jjco/hyt059. Epub 2013 Apr 25.
7
Role of chemotherapy in treatments for biliary tract cancer.化疗在胆管癌治疗中的作用。
J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):337-41. doi: 10.1007/s00534-011-0494-2.
8
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.吉西他滨联合索拉非尼对比吉西他滨单药治疗晚期胆道癌的双盲安慰剂对照多中心二期 AIO 研究：联合生物标志物和血清研究方案
Eur J Cancer. 2014 Dec;50(18):3125-35. doi: 10.1016/j.ejca.2014.09.013. Epub 2014 Oct 15.
9
A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy.一项奥沙利铂/5-FU（mFOLFOX）与伊立替康/5-FU（mFOLFIRI）化疗对比一线吉西他滨/顺铂化疗失败的局部晚期或转移性胆道癌的随机 II 期研究。
Eur J Cancer. 2021 Sep;154:288-295. doi: 10.1016/j.ejca.2021.06.019. Epub 2021 Jul 22.
10
How we treat advanced biliary tract cancers in the second-line setting.我们如何在二线治疗中治疗晚期胆管癌。
Clin Adv Hematol Oncol. 2023 Jan;21(1):35-42.